Skip to main content
GrowAG Logo
Opportunities

MLA: Pour-on Pain Relief Treatment EOI to Commercialise

Enquire nowWebsite link

Opportunity for

  • Companies to further develop and commercialise a novel pain relief pour-on treatment for Australian cattle.
     

Opportunity description

Industry challenge

Good pain management solutions are crucial for the future of the livestock industry. Consumers, producers and animal welfare groups are all looking for effective approaches for livestock pain control. Animal welfare concerns have now risen to third place in consumer buying decisions, just behind price and quality. Consumers want to know that the animals their products derive from have been treated humanely. Pain relief products that are economical, easy to administer, convenient, compliant and efficacious are required to assist with performance of animal husbandry procedures.

Current opportunity

A novel transdermal formulation containing a registered non steroidal anti-inflammatory drug has been developed to relieve pain and maintain the welfare of cattle and potentially other animals. The new cost-effective pour-on treatment delivers effective pain control, while alleviating issues with oral analgesic delivery and needle stick injuries.

The MLA Donor Company may co-invest with the successful commercialising party to progress the research and development of this work with the ultimate goal of a product release into the Australian market.

Further development may include: 

  • Formulation refinement
  • Techno-economic assessments
  • Process design
  • Field testing
  • Registration/regulatory plan

For more information or to register your interest in the new 
product, 'Enquire now' through growAG.

Opportunity background

Where is it up to? 

  • Initial cattle trials were successfully completed
  • The provisional patent application has been filed and, as of February 2026:
    • Granted: Australia, USA, Europe
    • Accepted: Canada
    • Under examination: New Zealand

 

MLA’s purpose is to foster the long-term prosperity of the Australian red meat and livestock industry by investing in research and marketing activities.

MLA Donor Company is a subsidiary company of MLA that accelerates innovation across the value chain so the Australian red meat and livestock industry can remain competitive on the world stage. It does this by attracting commercial investment from individual enterprises and others that share a mutual interest to co-invest in innovation that will benefit the industry.

 

"RDC"

Share